Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 100%High 0 · 0%

Mean number of new enhancing lesions Mean difference (IV, random, 95% CI) · patients with relapsing‐remitting multiple sclerosis

1 finding from 1 review

Interferons‐beta versus glatiramer acetate for relapsing‐remitting multiple sclerosis 2016 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 1734 participants
Moderate